Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Italiano

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
British Journal of Cancer|May 18, 2026
Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC)S Barraud, C Roussel-Simonin, P Pautier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2017
The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric seriesE Stoeckle, A Michot, L Rigal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2025
Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group studyP Sargos, M P Sunyach, A Ducassou, et al.
Targeted Oncology|December 25, 2012
Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implicationsA Italiano, E Saada, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group DatabaseA Italiano, F Delva, S Mathoulin-Pelissier, et al.
ESMO Open|June 29, 2024
Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus reportP Schöffski, R L Jones, M Agulnik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survivalD Garbay, R G Maki, J Y Blay, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 6, 2007
A comparison between distal and proximal port device insertion in head and neck cancerP-Y Marcy, E Chamorey, N Amoretti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2013
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupS Cousin, J Y Blay, F Bertucci, et al.
ESMO Open|September 24, 2025
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter studyP Schöffski, A Gazzah, J Trigo, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|May 18, 2026
Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC)S Barraud, C Roussel-Simonin, P Pautier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2017
The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric seriesE Stoeckle, A Michot, L Rigal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2025
Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group studyP Sargos, M P Sunyach, A Ducassou, et al.
Targeted Oncology|December 25, 2012
Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implicationsA Italiano, E Saada, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group DatabaseA Italiano, F Delva, S Mathoulin-Pelissier, et al.
ESMO Open|June 29, 2024
Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus reportP Schöffski, R L Jones, M Agulnik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survivalD Garbay, R G Maki, J Y Blay, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 6, 2007
A comparison between distal and proximal port device insertion in head and neck cancerP-Y Marcy, E Chamorey, N Amoretti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2013
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupS Cousin, J Y Blay, F Bertucci, et al.
ESMO Open|September 24, 2025
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter studyP Schöffski, A Gazzah, J Trigo, et al.
Pageof 14